Cefazolin: Clinical Trials

156 trials of Cefazolin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

83 completed, 27 unknown, 13 terminated, 12 recruiting. 55 Phase 4, 41 Not applicable, 27 Phase 3, 17 Phase 2, 10 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 455Completed 27, Not yet recruiting 5, Recruiting 5, Terminated 5, Unknown 5, Withdrawn 5, Enrolling by invitation 3
Not applicable41Completed 26, Unknown 9, Recruiting 2, Terminated 2, Enrolling by invitation 1, Withdrawn 1
Phase 327Completed 15, Unknown 5, Terminated 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 217Completed 6, Unknown 6, Recruiting 3, Terminated 2
Phase 110Completed 6, Unknown 3, Active not recruiting 1
Early Phase 13Completed 2, Unknown 1

Follow Cefazolin: new trials by email Literature Review of Cefazolin trials Research Report on Cefazolin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin
Cefazolin 2 g Infusion, Placebo infusion of .9 normal saline - Breast Cancer, Breast Surgery
Phase 3Not yet recruitingUniversity Hospital, Clermont-Ferrand16002026-11-012026-10-27
Azithromycin for Cerclage Prophylaxis
Azithromycin Prophylaxis, Azithromycin Placebo, Cefazolin - Cervical Insufficiency
Phase 4Not yet recruitingWake Forest University Health Sciences802026-10-152026-10-27
Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During Orthopedic Surgeries in Egyptian Patients.
Cefazolin 2 g Infusion, Cefazolin 2 GM Injection - Surgical Site Infection (SSI)
Phase 4Not yet recruitingHelwan University1002026-07-012026-06-24
Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients.
Cefazolin 2 g Infusion, Cefazolin 2 GM Injection - Surgical Site Infection (SSI)
Phase 4Not yet recruitingHelwan University1002026-07-012026-06-24
Duration of Perioperative Antibiotics in Pancreatoduodenectomy
single dose preoperative antibiotic, Prolonged perioperative antibiotics - Pancreatoduodenectomy, PPPD
Not applicableEnrolling by invitationAsan Medical Center5582026-05-112026-05-28
Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial
Cefazolin, Vancomycin - Infection, Surgical Site
Phase 4Not yet recruitingHamilton Health Sciences Corporation380002026-03-012026-03-12
Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement
CeFAZolin 1000 MG, Saline (0.9%, sterile, for infusion) - Antibiotic Prophylaxis Surgery
Phase 4Enrolling by invitationRutgers, The State University of New Jersey252025-10-202026-04-29
Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?
Early Dual IV Antibiotic Therapy - MRSA, Early Dual IV Antibiotic Therapy - MSSA, Single Agent IV Antibiotic Therapy - MRSA - Staphylococcus Aureus Bacteremia
Phase 4Enrolling by invitationWest Virginia University3002025-09-152026-09-17
Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic
Cefazolin plus Gentamicin, Cefazolin - Surgical Site Infection (SSI)
Not applicableCompletedLahore General Hospital2842025-07-012026-03-18
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy
Phase 2RecruitingMassachusetts General Hospital3002025-05-052026-09-04
PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network
Ertapenem, Cefazolin and Metronidazole. - Surgical Site Infection
Phase 4Not yet recruitingThe University of Texas Health Science Center, Houston3002025-05-012025-04-11
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
Azithromycin, Placebo - Obesity in Pregnancy, Labor Complication
Phase 2RecruitingUniversity of Oklahoma7872025-04-292026-03-12
Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement
• Cefamezine (2 grams) and gentamicin (80 mg) administered intravenously. • Patients with penicillin allergies, a history of methicillin-resistant Staphylococcus aureus (MRSA) infection, or known MRSA - Infection Catheter-Related
Phase 4RecruitingWestern Galilee Hospital-Nahariya2002024-10-282025-02-07
Antibiotic Prophylaxis in Metabolic Bariatric Surgery
2000 mg of Cefazolin, 500 mg of Metronidazole IV, NACL 0.9% 100 ml - Antibiotic Reaction, Wound Infection Superficial
Not applicableUnknownGeneral Committee of Teaching Hospitals and Institutes, Egypt33522024-10-012024-07-31
The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients
Cefazolin 1000 MG - Antibiotic Prophylaxis, Wound Infection
Phase 3UnknownUniversity of Aleppo2002024-08-012024-08-28
Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial
Cefazolin with Daptomycin, Cefazolin with vancomycin - Periprosthetic Joint Infection
Not applicableUnknownChang Gung Memorial Hospital1842024-08-012024-01-05
Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia
Tab. Trimethoprim-sulfamethoxazole, Tab. Clindamycin, Tab. Cephalexin, or Tab. Linezolid, IV Cloxacillin, IV Cefazolin, IV Vancomycin, or IV Ceftaroline - Staphylococcus Aureus Bacteremia
Phase 3UnknownClinical Research Centre, Malaysia2902024-06-282024-07-05
Antibiotic Tumescent For Chronic Wounds
CeFAZolin Injectable Solution - Non-healing Wound
Phase 2RecruitingUniversity of California, Los Angeles602024-05-172026-04-23
Antibiotics for Prevention of Infection Following Orthognathic Surgery
Cefazolin 2 GM Injection, Cefazolin Injection - Orthognathic Surgical Site Infection
Phase 4RecruitingAbdul El-Rabbany4002024-01-092026-03-19
Randomized Assessment of Antibiotic Prophylaxis Prior to Port Placement
Cefazolin, saline - Vascular Access Ports
Not applicableWithdrawnDartmouth-Hitchcock Medical Center2024-01-012024-04-26

Showing 20 of 156. Sign in to see all of them.

Conditions studied

Surgical Wound Infection (28)  ·  Infections (18)  ·  Wound Infection (11)  ·  Staphylococcal Infections (7)  ·  Bacteremia (6)  ·  Breast Neoplasms (5)  ·  Obesity (5)  ·  Communicable Diseases (4)  ·  Osteomyelitis (4)  ·  Arthritis, Infectious (3)  ·  Cellulitis (3)  ·  Hernia, Inguinal (3)  ·  Sepsis (3)  ·  Uterine Cervical Incompetence (3)  ·  Appendicitis (2)

Sponsors

Population Health Research Institute (4)  ·  Duke University (3)  ·  West Virginia University (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  B. Braun Medical Inc. (2)  ·  Chinese University of Hong Kong (2)  ·  HaEmek Medical Center, Israel (2)  ·  Hamilton Health Sciences Corporation (2)  ·  Helwan University (2)  ·  Hospital for Special Surgery, New York (2)  ·  Isfahan University of Medical Sciences (2)  ·  McMaster University (2)  ·  Radboud University Medical Center (2)  ·  Rush University Medical Center (2)  ·  Samsung Medical Center (2)

Countries

United States (66)  ·  Canada (19)  ·  Brazil (8)  ·  Israel (8)  ·  Netherlands (8)  ·  Australia (6)  ·  France (6)  ·  Egypt (4)  ·  Iran (4)  ·  New Zealand (4)  ·  Singapore (4)  ·  South Korea (4)  ·  Spain (4)  ·  Malaysia (3)  ·  South Africa (3)

Top investigators

Daniela F Veiga, MD, PhD (2)  ·  Dominik Mertz, MD, MSc (2)  ·  Michael L Stitely, MD (2)  ·  Stephanie Pierce, MD (2)  ·  William H Holls, MD (2)  ·  Achim J Kaasch, MD (1)  ·  Adriano Germano, PhD (1)  ·  Ahmed M. Ibrahim Taha, Dr (1)  ·  Alan G Smulian, M.B.B.Ch. (1)  ·  Alena Jamdourek, MD (1)  ·  Alexandra Zhernakova, MD/PhD (1)  ·  Allison R Lauver, PharmD (1)  ·  Allison Rao, MD (1)  ·  Amanda Gwee, PhD (1)  ·  Anca Amza (1)

Results publications

PMID 10219875, PMID 10998650, PMID 12841893, PMID 18839083, PMID 19376733, PMID 20934625, PMID 21126927, PMID 21412147, PMID 21601826, PMID 22083832, PMID 23052809, PMID 23325435, PMID 23461695, PMID 24807330, PMID 25376070, PMID 25532706, PMID 25932849, PMID 26452342, PMID 27029920, PMID 27106640, PMID 27412673, PMID 27682068, PMID 28505360, PMID 29146633, PMID 29279933, PMID 29793587, PMID 29914924, PMID 30027615, PMID 30173161, PMID 30234517, PMID 30264119, PMID 30545448, PMID 30558680, PMID 30995208, PMID 31236724, PMID 31331757, PMID 31737738, PMID 31806127, PMID 31993070, PMID 32044943, PMID 32051007, PMID 32557558, PMID 33239101, PMID 33395210, PMID 33416442, PMID 33618788, PMID 33743753, PMID 33752752, PMID 34499720, PMID 34825283

NIH funding

2014 (1), 2025 (1), 5UM1AI104681-12 (1), K23HD060040 (1), U01AI184071 (1)